Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-27 16:17 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
2,280,786 | |
Filed 2024-06-10 16:56 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$156,332
+411,402 vol $0.38 each |
5,762,802 | |
Filed 2024-06-10 16:55 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-550,000 vol |
1,930,786 | |
Filed 2023-12-22 10:58 Tx date 2023-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |
Filed 2023-10-02 21:27 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,480,786 | |
Filed 2023-02-22 16:15 Tx date 2023-02-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,600
+30,000 vol $0.92 each |
5,351,400 | |
Filed 2022-06-28 16:07 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$587,250
+405,000 vol $1.45 each |
1,980,786 | |
Filed 2022-01-21 10:54 Tx date 2022-01-19 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$962.00
+500 vol $1.92 each |
5,321,400 | |
Filed 2022-01-21 10:53 Tx date 2022-01-19 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,552
+800 vol $1.94 each |
5,320,900 | |
Filed 2022-01-21 10:52 Tx date 2022-01-19 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,061
+11,700 vol $1.89 each |
5,320,100 | |
Filed 2021-11-08 13:06 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,690
+24,700 vol $2.70 each |
5,308,400 | |
Filed 2021-11-08 13:06 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,643
+4,700 vol $2.69 each |
5,283,700 | |
Filed 2021-11-08 13:06 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$268.00
+100 vol $2.68 each |
5,279,000 | |
Filed 2021-11-08 13:05 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,370
+5,800 vol $2.65 each |
5,278,900 | |
Filed 2021-11-08 13:05 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$264.00
+100 vol $2.64 each |
5,273,100 | |
Filed 2021-11-08 13:05 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,786
+2,200 vol $2.63 each |
5,273,000 | |
Filed 2021-11-08 13:04 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,454
+1,700 vol $2.62 each |
5,270,800 | |
Filed 2021-11-08 13:04 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260.00
+100 vol $2.60 each |
5,269,100 | |
Filed 2021-11-03 15:17 Tx date 2021-11-02 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,975
+9,000 vol $2.77 each |
5,269,000 | |
Filed 2021-09-24 17:34 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$623,249
+198,487 vol $3.14 each |
1,575,786 | |
Filed 2021-01-07 09:30 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,656
+9,200 vol $5.18 each |
5,260,000 | |
Filed 2021-01-07 09:29 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,068
+400 vol $5.17 each |
5,250,800 | |
Filed 2021-01-07 09:28 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,028
+200 vol $5.14 each |
5,250,400 | |
Filed 2021-01-07 09:28 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,026
+200 vol $5.13 each |
5,250,200 | |
Filed 2020-11-05 09:15 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$394,997
+77,299 vol $5.11 each |
1,377,299 | |
Filed 2019-11-11 16:22 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$390,000
+300,000 vol $1.30 each |
1,300,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+300,000 vol $1.00 each |
1,000,000 | |
Filed 2018-12-27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$120,000
+100,000 vol $1.20 each |
100,000 | |
Filed 2018-12-22 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,000
+200,000 vol $1.00 each |
5,250,000 | |
Filed 2017-09-26 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$703,499
+350,000 vol $2.01 each |
700,000 | |
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,050,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,500,000 |